$1.86 million.

$1.86 million. That was Oklo's entire Q3 revenue, all from engineering, consulting, manufacturing and fabrication services. My read: the DOE clearance for Groves-1 is real progress, but the number I'd watch is when reactor output starts showing up next to that $1.86 million.

• On Nov 11, BusinessWire reported DOE cleared the final operations hold point for the Groves Isotope Test Reactor, Groves-1, letting it advance into its research, testing and training phase. That permits the work. It doesn't mean isotopes or data are coming out yet.
• Per the Nov 6 earnings call, DOE had already approved the preliminary documented safety analysis that enabled construction. Next-gen nuclear moves through a chain of sequential sign-offs, and that pace is the bottleneck for anyone counting on it to power AI.
• OKLO trades at $26.905 pre-market, up 7.23% from its last close of $25.09, which itself was down 6.52%. The bigger recent move came Nov 6, when shares reportedly rose about 22.6% after an EPS and revenue beat.

I'm wary of nuclear hype getting ahead of revenue, so I'd treat this as a checkpoint cleared, not a business proven. The first isotopes or test data out of Groves-1 would change my read, though I could be wrong on timing.

Source:
BusinessWire: https://www.businesswire.com/news/home/20261111613764/en/Oklo%E2%80%99s-Groves-1-to-Begin-Research-and-Demonstration-Phase-after-being-Cleared-by-U.S.-Department-of-Energy-for-Unrestricted-Operations/

Not financial advice. For informational and educational purposes only.